COO Cooper Companies Inc.

CooperCompanies Announces Release Date for Fourth Quarter and Full Year 2020

CooperCompanies Announces Release Date for Fourth Quarter and Full Year 2020

SAN RAMON, Calif., Nov. 03, 2020 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced it will release fourth quarter and full year 2020 financial results on Thursday, December 3, 2020, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments.

The live dial-in number for the call is 855-643-4430 (U.S.) / 707-294-1332 (International). The participant passcode for the call is “Cooper”. A simultaneous webcast of the call will be available through the “Investor Relations” section of the CooperCompanies website at and a transcript of the call will be archived on this site for a minimum of 12 months.

A recording of the call will be available beginning at 8:00 PM ET on December 3, 2020 through December 10, 2020. To hear this recording, dial 855-859-2056 (U.S.) / 404-537-3406 (International) and enter code 5599209.

About CooperCompanies

CooperCompanies ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, CA, Cooper has a workforce of more than 12,000 with products sold in over 100 countries. For more information, please visit .

Contact:

Kim Duncan

Vice President, Investor Relations and Risk Management

925-460-3663

EN
03/11/2020

Underlying

COOCooper Companies Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Cooper Companies Inc.

 PRESS RELEASE
Free
COO Cooper Companie...

CooperCompanies Announces Expanded Share Repurchase Program

CooperCompanies Announces Expanded Share Repurchase Program SAN RAMON, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today its Board of Directors has approved a $1 billion increase in the Company’s share repurchase program. The share repurchase program now totals $2 billion. “We are pleased to announce that our Board of Directors has authorized an increase to our share repurchase program,” said Al White, President and Chief Executive Officer. “This decision underscores the strength of our balance sheet and cas...

September 17, 2025 1 EN
Free Trial
COO Cooper Companie...

Cooper Companies Inc: 2 directors

Two Directors at Cooper Companies Inc bought 11,450 shares at between 68.390USD and 69.230USD. The significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors ov...

COO COOPER COMPANIES INC.
09/05/25 September 5, 2025 1 EN
 PRESS RELEASE
Free
COO Cooper Companie...

CooperCompanies Announces Third Quarter 2025 Results

CooperCompanies Announces Third Quarter 2025 Results SAN RAMON, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal third quarter ended July 31, 2025. Revenue increased 6% year-over-year to $1,060.3 million. CooperVision (CVI) revenue up 6% to $718.4 million, and CooperSurgical (CSI) revenue up 4% to $341.9 million.GAAP diluted earnings per share (EPS) of $0.49, down $0.03 or 6% from last year's third quarter.Non-GAAP diluted EPS of $1.10, up $0.14 or 15% from last year's ...

August 27, 2025 1 EN
 PRESS RELEASE
Free
COO Cooper Companie...

CooperCompanies to Participate in the Wells Fargo Healthcare Conferenc...

CooperCompanies to Participate in the Wells Fargo Healthcare Conference SAN RAMON, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today it will participate in the Wells Fargo Healthcare Conference on Wednesday, September 3, 2025. Al White, President and CEO, will represent the Company in a session scheduled at 3:00 PM ET. The webcast will be available to investors and other interested parties by accessing the CooperCompanies’ website at . About CooperCompaniesCooperCompanies (Nasdaq: COO) is a leading global me...

August 14, 2025 1 EN
 PRESS RELEASE
Free
COO Cooper Companie...

CooperCompanies Announces Release Date for Third Quarter 2025

CooperCompanies Announces Release Date for Third Quarter 2025 SAN RAMON, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading medical device company, announced today it will report third quarter 2025 financial results on Wednesday, August 27, 2025, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments. The dial-in number for the call is 800-715-9871 and the conference ID is 3665386. A simultaneous audio webcast and subsequent replay can be accessed at . About...

July 24, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch